SC
DXCM icon

Stance Capital’s DexCom DXCM Stock Holding History

Stance Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.9K Buy
+699
New +$48.7K 0.02% 153
2025
Q4 		– Sell
-666
Closed -$44.8K – 179
2025
Q3 		$44.8K Buy
+666
New +$52.7K 0.02% 187

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stance Capital's DXCM Position: Q1 2026 in Review

Stance Capital opened a new position in DexCom (DXCM) in Q1 2026: 699 shares worth $43.9K. The stake represents 0.02% of the portfolio and ranks #153 among its holdings. This is a return to the name: Stance Capital previously reported a position in DXCM as recently as Q3 2025.

Stance Capital first reported a position in DXCM in Q3 2025 and has held it in 2 quarters since. The position peaked at $44.8K in Q3 2025. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Stance Capital held 699 shares of DexCom worth $43.9K as of Q1 2026.
  • DexCom was a new Stance Capital position in Q1 2026.
  • DexCom made up 0.02% of Stance Capital's portfolio in Q1 2026, its #153 holding.
  • Stance Capital first reported a position in DexCom in Q3 2025 and has held it in 2 quarters since.
  • Stance Capital's DexCom position peaked at $44.8K in Q3 2025.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.